ClinicalTrials.gg
Not yet recruitingNCT07826702Updated Sep 23, 2026

Nonviolent Communication Plus Personalised E-message for Parents

An interventional study of Healthy Lifestyle Tips and Nonviolent Communication Intervention & Personalised E-messages in Family Conflict and Relationship, Parent Child, sponsored by Hong Kong Metropolitan University. Not yet recruiting at 1 site in Hong Kong. Open to participants aged 32 Years to 59 Years. Per ClinicalTrials.gov, last updated 2026-09-23.

Sponsored by Hong Kong Metropolitan University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
32 Years to 59 Years
Sex
All
01

Study summary

This pilot randomised controlled trial (RCT) aims to evaluate the feasibility, acceptability, and preliminary effects of combining a brief Nonviolent Communication (NVC) intervention with follow-up personalised AI-generated messages delivered daily via WhatsApp to improve child-parent relationships, parenting competence and family communication.

A total of 60 parents of middle school students experiencing difficulties in family communication or recurrent conflict with their children will be recruited in Hong Kong and randomly assigned (in a 1:1 allocation ratio) to an intervention group or an attention control group.

The intervention group will participate in two 2-hour NVC workshops, scheduled two weeks apart and delivered by the principal investigator, plus four weeks of personalised AI-generated NVC e-messages daily. The attention control group will receive weekly e-messages with healthy lifestyle tips for 6 weeks.

Assessments for participants will be conducted at baseline (T0), post-workshop (T1, after the second session/two weeks after T0), and 12 weeks after baseline (T2). A process evaluation featuring quantitative ratings and open-ended questions will be conducted to explore participants' perceived benefits and subjective experiences.

02

Conditions studied

  • Family Conflict
  • Relationship, Parent Child

Keywords

  • Nonviolent Communication
  • Text Messaging
  • Randomized Controlled Trial
  • Relationship, Parent Child
03

In context

Lead sponsor

Hong Kong Metropolitan University is the lead sponsor of 56 studies on the registry; 31 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
32 Years to 59 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 1) parents aged 32-59 years with children attending middle school (approximately 12-17 years old) in Hong Kong;
  • 2) scoring 3 or above in any item of the 3-item conflict subscale of the Network of Relationship Inventory (Furman \& Buhrmester, 2009);
  • 3) able to read Chinese and use a smartphone to receive WhatsApp messages;
  • 4) willingness to attend a two-session NVC intervention in group format.

Exclusion criteria

Exclusion Criteria:

  • 1) severe mental health problems requiring immediate specialist care or inability to provide .
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    NVC Intervention Group

    Participants in the intervention group will receive two 2-hour NVC intervention workshops, scheduled two weeks apart and delivered in small groups (either online or face-to-face) by the PI, plus four weeks of daily personalised AI-generated NVC messages via WhatsApp.

    Behavioral: Nonviolent Communication Intervention & Personalised E-messages

  • Active comparator
    Attention Control Group

    Participants in the attention control group will not receive any NVC intervention workshops during the study. They will receive regular healthy lifestyle information messages via WhatsApp for 6 weeks.

    Behavioral: Healthy Lifestyle Tips

Interventions

  • BehavioralHealthy Lifestyle Tips

    The attention control group will receive an information pamphlet that encourages them to maintain a healthy diet, engage in regular physical activity, and practice weight control. Participants will receive weekly WhatsApp messages about healthy lifestyle tips for 6 weeks.

  • BehavioralNonviolent Communication Intervention & Personalised E-messages

    The intervention includes an introduction to NVC's four principles, the difference between observations and judgments, identifying and expressing feelings, taking responsibility for feelings and needs, and using positive action language when making requests. The intervention workshops will be offered in rolling monthly cycles for approximately three rounds over three months (two rounds will be online, and one will be face-to-face). Participants who miss the second session may attend an equivalent session in the second or third cycle. Between and following the sessions, participants will receive AI-generated, tailored messages via WhatsApp daily for four weeks that provide concise NVC tips and guide parents through NVC-style conversations with their adolescents.

06

What researchers measure

Primary outcomes

  1. Recruitment rate

    Recruitment rate is defined as the proportion of eligible or contacted candidates who actually agree to join the study (Number Enrolled / Number Eligible or Approached).

    Time frame: Baseline (T0)

  2. Retention rate

    Retention rate is defined as the percentage of randomised participants retained and assessed with valid primary outcome data.

    Time frame: 12-week assessment (T2, around 3 months after baseline)

Secondary outcomes

  1. Child-Parent Relationship

    The Child-Parent Relationship Scale (CPRS-SF) is a 15-item scale for evaluating two dimensions of the relationship between parents and children: conflict and closeness. Items are rated on a 5-point Likert scale ranging from 1 ("strongly disagree") to 5 ("strongly agree"). Scores for closeness and conflict are calculated separately, with higher closeness scores indicating a stronger emotional bond and a supportive relationship between parents and children (Driscoll \& Pianta, 2011). Higher conflict scores indicate greater conflict between parents and children. The internal consistency reliabilities were adequate in a Chinese sample (Cronbach's alpha = 0.78 to 0.81) (Tan et al., 2023).

    Time frame: Baseline (T0), Post-workshop assessment (T1, 2 weeks after T0), and 12-week assessment (T2, around 3 months after T0).

  2. Parenting Competence

    The Parenting Sense of Competence Scale (PSOC) (Ngai et al., 2007) is a 17-item scale to measure parents' perceived competence in the parenting role. Each item is rated on a 6-point Likert scale ranging from 1 (strongly disagree) to 6 (strongly agree). Higher scores indicate greater competence in parenting. Cronbach's alpha was 0.93 in a Chinese sample.

    Time frame: Baseline (T0), Post-workshop assessment (T1, 2 weeks after T0), and 12-week assessment (T2, around 3 months after T0).

  3. Family function

    The Family Communication Scale (FCS) is a 10-item scale used to measure family communication (Guo et al., 2021). Items are rated on a 5-point Likert scale, ranging from 1 ("strongly disagree") to 5 ("strongly agree"). A higher total score (range 10-50) indicates a higher level of positive family communication. The Chinese version of FCS showed good internal consistency (Cronbach's alpha = 0.91) and was stable over 1 month (intraclass correlation coefficient = 0.69).

    Time frame: Baseline (T0), Post-workshop assessment (T1, 2 weeks after T0), and 12-week assessment (T2, around 3 months after T0).

  4. Anxiety

    The Generalized Anxiety Disorder (GAD)-7 scale is a 7-item instrument to assess anxiety symptoms in the past two weeks (Spitzer et al., 2006; Tong et al., 2016). Each item is scored from 0 to 3. The seven item scores are summed to yield a total score ranging from 0 to 21, with higher scores indicating greater anxiety symptom severity.

    Time frame: Baseline (T0), Post-workshop assessment (T1, 2 weeks after T0), and 12-week assessment (T2, around 3 months after T0).

Other outcomes

  1. Perceived Benefits

    Evaluated through process evaluation metrics assessing perceived benefits, subjective changes in personal mental health, and happiness. Participants rate overall satisfaction on a 0-10 scale, with 0 indicating "very dissatisfied" and 10 indicating "very satisfied". Open-ended questions will also collect participants' comments and suggestions.

    Time frame: Post-workshop assessment (T1) and 12-week assessment (T2, around 3 months after T0)

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No — We are not sharing individual participant data (IPD) due to privacy concerns and limitations in participant consent. Although the data is de-identified, there remains a risk of re-identification, and participants were not explicitly consented for public data sharing. Aggregate results will be made available through publications and presentations to ensure transparency.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Oct 2026; primary completion for Jun 2027, 8 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 14, 2026
First posted
Sep 17, 2026
StartEst.
Oct 2026
Primary completionEst.
Jun 30, 2027
CompletionEst.
Sep 30, 2027
Last update
Sep 23, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07826702
Lead sponsor
Hong Kong Metropolitan University
Responsible party
Dr Grace SUN Yuying (Assistant Professor, Hong Kong Metropolitan University) — Principal investigator
First posted
Sep 17, 2026
Start date
Oct 2026 (estimated)
Primary completion
Jun 30, 2027 (estimated)
Completion
Sep 30, 2027 (estimated)
Last update
Sep 23, 2026

Study contacts

Yuying Sun, PhD
Contact
gsun@hkmu.edu.hk
852 39702916
Yuying Sun, PhD
principal investigator · Hong Kong Metropolitan University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion